327 related articles for article (PubMed ID: 27693059)
1. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
[TBL] [Abstract][Full Text] [Related]
2. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
Hindie V; Lopez-Garcia LA; Biondi RM
Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
[TBL] [Abstract][Full Text] [Related]
4. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
[TBL] [Abstract][Full Text] [Related]
5. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.
Xu X; Chen Y; Fu Q; Ni D; Zhang J; Li X; Lu S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):361-374. PubMed ID: 30734603
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
[TBL] [Abstract][Full Text] [Related]
7. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.
Biondi RM; Komander D; Thomas CC; Lizcano JM; Deak M; Alessi DR; van Aalten DM
EMBO J; 2002 Aug; 21(16):4219-28. PubMed ID: 12169624
[TBL] [Abstract][Full Text] [Related]
8. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
[TBL] [Abstract][Full Text] [Related]
9. AGC kinases, mechanisms of regulation and innovative drug development.
Leroux AE; Schulze JO; Biondi RM
Semin Cancer Biol; 2018 Feb; 48():1-17. PubMed ID: 28591657
[TBL] [Abstract][Full Text] [Related]
10. Allosteric Regulation of Protein Kinases Downstream of PI3-Kinase Signalling.
Leroux AE; Gross LZF; Sacerdoti M; Biondi RM
Adv Exp Med Biol; 2019; 1163():279-311. PubMed ID: 31707708
[TBL] [Abstract][Full Text] [Related]
11. 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.
Wilhelm A; Lopez-Garcia LA; Busschots K; Fröhner W; Maurer F; Boettcher S; Zhang H; Schulze JO; Biondi RM; Engel M
J Med Chem; 2012 Nov; 55(22):9817-30. PubMed ID: 23106316
[TBL] [Abstract][Full Text] [Related]
12. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA.
Biondi RM; Cheung PC; Casamayor A; Deak M; Currie RA; Alessi DR
EMBO J; 2000 Mar; 19(5):979-88. PubMed ID: 10698939
[TBL] [Abstract][Full Text] [Related]
14. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
Najafov A; Shpiro N; Alessi DR
Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
[TBL] [Abstract][Full Text] [Related]
15. Turning a protein kinase on or off from a single allosteric site via disulfide trapping.
Sadowsky JD; Burlingame MA; Wolan DW; McClendon CL; Jacobson MP; Wells JA
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6056-61. PubMed ID: 21430264
[TBL] [Abstract][Full Text] [Related]
16. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
[TBL] [Abstract][Full Text] [Related]
17. Discovery of SBF1 as an allosteric inhibitor targeting the PIF-pocket of 3-phosphoinositide-dependent protein kinase-1.
Liu W; Li P; Mei Y
J Mol Model; 2019 Jun; 25(7):187. PubMed ID: 31197600
[TBL] [Abstract][Full Text] [Related]
18. AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases.
Arencibia JM; Pastor-Flores D; Bauer AF; Schulze JO; Biondi RM
Biochim Biophys Acta; 2013 Jul; 1834(7):1302-21. PubMed ID: 23524293
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Characterization of Allosteric WNK Kinase Inhibitors.
Yamada K; Zhang JH; Xie X; Reinhardt J; Xie AQ; LaSala D; Kohls D; Yowe D; Burdick D; Yoshisue H; Wakai H; Schmidt I; Gunawan J; Yasoshima K; Yue QK; Kato M; Mogi M; Idamakanti N; Kreder N; Drueckes P; Pandey P; Kawanami T; Huang W; Yagi YI; Deng Z; Park HM
ACS Chem Biol; 2016 Dec; 11(12):3338-3346. PubMed ID: 27712055
[TBL] [Abstract][Full Text] [Related]
20. Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
Hindie V; Stroba A; Zhang H; Lopez-Garcia LA; Idrissova L; Zeuzem S; Hirschberg D; Schaeffer F; Jørgensen TJ; Engel M; Alzari PM; Biondi RM
Nat Chem Biol; 2009 Oct; 5(10):758-64. PubMed ID: 19718043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
